J
Jiuliang Zhao
Researcher at Peking Union Medical College Hospital
Publications - 186
Citations - 1711
Jiuliang Zhao is an academic researcher from Peking Union Medical College Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 124 publications receiving 980 citations. Previous affiliations of Jiuliang Zhao include Chinese Ministry of Science and Technology & Chinese Ministry of Education.
Papers
More filters
Journal ArticleDOI
JAK Inhibitors: Prospects in Connective Tissue Diseases
TL;DR: JAK inhibitors have great potential for the treatment of various CTDs by reducing multiple cytokine production and suppressing inflammation, with the advantages of rapid onset in an oral formulation and decreased corticosteroid dependence and the associated adverse events, especially in refractory cases.
Journal ArticleDOI
Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China
Jiuliang Zhao,Qian Wang,Yongtai Liu,Zhuang Tian,Xiaoxiao Guo,Hui Wang,Jinzhi Lai,Can Huang,Xiaoxi Yang,Mengtao Li,Xiaofeng Zeng +10 more
TL;DR: Investigation of the clinical characteristics and survival of CTD-PAH in Chinese patients with systemic lupus erythematosus, systemic sclerosis, or primary Sjögren's syndrome found independent predictors of mortality for PAH were 6MWD <380m and SSc as the underlying CTD.
Journal ArticleDOI
Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus
Mingxi Li,Qian Wang,Jiuliang Zhao,Zhijun Li,Zhizhong Ye,Caifeng Li,X Li,Ping Zhu,Zhengang Wang,Yi Zheng,Miaojia Zhang,Zhuang Tian,Yongtai Liu,Jing He,Fengchun Zhang,Yupei Zhao,Xuejun Zeng +16 more
TL;DR: The significant association of pericarditis, pleuritis and anti-RNP positivity with PAH suggests that higher disease activity and vasculopathy may both contribute to the development of PAH in SLE, which need to be treated aggressively to improve prognosis.
Journal ArticleDOI
Long-Term Survival and Death Causes of Systemic Lupus Erythematosus in China: A Systemic Review of Observational Studies
Ziqian Wang,Yanhong Wang,Rongrong Zhu,Xinping Tian,Dong Xu,Qian Wang,Chanyuan Wu,Shangzhu Zhang,Jiuliang Zhao,Yan Zhao,Mengtao Li,Xiaofeng Zeng +11 more
TL;DR: The overall survival rates for Chinese patients with SLE resembled previous publications in Asia-Pacific area, but the death causes of SLE in China were of some differences indicating relatively higher proportion of infection and lupus encephalopathy and lower cardiovascular disease.
Journal ArticleDOI
Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients
Can Huang,Mengtao Li,Yongtai Liu,Qian Wang,Xiaoxiao Guo,Jiuliang Zhao,Jinzhi Lai,Zhuang Tian,Yan Zhao,Xiaofeng Zeng +9 more
TL;DR: The PUMCH study has shown that SLE patients complicated with PAH are usually earlier diagnosed and have less disease severity than patients without PAH.